Pharmaceutical

New ixlayer Survey Finds 73% of Pharma Leaders Are Running or Planning to Launch a DTP Program in the Next Year, and Half Say DTP Will Be Standard Practice Within Five Years

82% say fragmented care continues to undermine DTC advertising effectiveness, signaling the need for a new strategy SAN FRANCISCO, Sept.…

3 months ago

Primum Health Raises Seed Round Led by FCA Venture Partners and North Coast Ventures

Funding will fuel rapid expansion of the Columbus-based oncology platform, which connects community oncologists with subspecialty experts and real-world insights…

3 months ago

Medical Care Technologies Inc. Expands AI Platform to Detect Glaucoma and Cataracts

MESA, ARIZONA / ACCESS Newswire / September 25, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced that its AI…

3 months ago

Alliance for Pharmacy Compounding Joins Pharmacy Podcast Network with New “Essential” Podcast

With podcasting reaching over 210M people in the United States today, building reliable content for Providers and business professionals in…

3 months ago

Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Company strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment…

3 months ago

Smile Digital Health Pledges Foundational Technology Support to Power the CMS Health Tech Ecosystem

TORONTO, ON / ACCESS Newswire / September 25, 2025 / Smile Digital Health, a provider of enterprise-grade, open-framework health data…

3 months ago

Dr. Ran Rubinstein Explains His Sculptra Approach to Natural Volume Restoration

By combining experience in facial anatomy with advanced Sculptra injection strategies, Dr. Ran Rubinstein helps patients achieve gradual, long-lasting improvements…

3 months ago

AIM ImmunoTech Secures Patent in Japan Through 2039 for Novel Cancer Therapy Combining Ampligen® (Rintatolimod) with Checkpoint Inhibitors

Patent supports AIM’s strategy to expand international market protection, providing opportunities for licensing, collaborations, and long-term revenue growth Japan is…

3 months ago

Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin

HOUSTON, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company…

3 months ago

LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced…

3 months ago